AEON Biopharma (AEON) Income Statement: Revenue & Earnings

AEON Biopharma Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

AEON Biopharma, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	0.00	0.00	0.00	0.00	2.52
Cost of Revenue	0.00	0.00	0.00	0.00	0.00
Gross Profit	0.00	0.00	0.00	0.00	2.52
Operating Expenses
Research & Development	14.18	13.24	34.75	25.73	7.32
Selling, General & Administrative	13.64	357.95	13.68	11.15	11.59
Operating Expenses	27.82	318.44	48.43	36.88	18.91
Operating Income	-27.82	-318.44	-48.43	-36.88	-16.39
Other Income/Expense
Interest Income	0.00	0.00	0.00	0.00	0.00
Interest Expense	0.00	0.00	0.00	0.00	-0.02
Other Income/Expense	-34.29	-2.85	0.29	-18.76	-0.12
Income
Income Before Tax	42.01	-323.95	-52.56	-55.64	-32.91
Income Tax Expense	0.00	0.00	0.00	0.00	0.00
Net Income	42.01	-323.95	-52.56	-55.64	-32.91
Net Income - Continuous Operations	42.01	0.00	-52.56	-55.64	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-27.73	-323.91	-48.36	-36.88	-15.51
EBIT	-27.82	-323.95	-48.43	-36.88	-16.39
Depreciation & Amortization	0.10	0.10	0.07	0.00	0.88
Earnings Per Share
Basic EPS	78.00	47.00	-27.00	-182.00	-548.00
Diluted EPS	73.00	47.00	-27.00	-182.00	-548.00
Basic Shares Outstanding	0.54	0.52	1.93	0.31	0.09
Diluted Shares Outstanding	0.58	0.52	1.93	0.31	0.09